Aetna provider study reveals optimism and opportunities to simplify health care
Survey highlights opportunities to deepen trust across the provider-payer relationship.
Survey highlights opportunities to deepen trust across the provider-payer relationship.
Wegovy HD available through over 70,000 U.S. pharmacies, NovoCare Pharmacy, select telehealth providers, and more/
First prescription ear drop suspension advances portfolio diversification strategy.
The event provided a platform for early-stage biotech companies to showcase their science, enhance visibility, and engage with potential collaborators across the drug discovery ecosystem.
Why pharmacy operators should rethink infrastructure before the next disruption hits.
The tariffs will come into effect in 120 days for certain large companies, and 180 days for smaller companies.
“This decision will help enhance the generic medicines supply chain."
New facility lets NCPA create more engaging content for independent pharmacists on multiple media platforms.
The purchase includes 14 NuCara Retail Pharmacies and 10 NuCara Home Medical stores.
Baird brings nearly 20 years of experience leading the operations of Aetna Medicaid health plans, while Pleasants brings more than 15 years of experience supporting Medicaid populations.
The discount card platform is disrupting a multi-billion-dollar industry in just four years.
As detailed in the HDA Research Foundation’s 2025 Specialty Pharmaceutical Distribution Facts, Figures and Trends, specialty distributors are meeting the greater demand through innovation and coordination across the healthcare supply chain.
GenieRx will serve as the "stalking horse bidder" in the company's ongoing court‑supervised sale process.
Oral GLP-1 therapy achieves double-digit weight loss in trials and launches this month with no food or water restrictions, expanding access through retail and direct-to-consumer channels.
Advanced automation and connected data capabilities strengthen medication inventory control and enhance safety across pharmacy settings.
Move to support growing demand for novel cancer therapies